We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBAY icon
101
eBay
EBAY
$52.1B
$43.4M 0.22%
498,323
-3,837
-0.8% -$332K
BAP icon
102
Credicorp
BAP
$30.8B
$43.4M 0.22%
151,200
-17,190
-10% -$4.55M
SNPS icon
103
Synopsys
SNPS
$73.5B
$42.6M 0.21%
90,612
-3,027
-3% -$1.34M
SYF icon
104
Synchrony
SYF
$24.9B
$42.3M 0.21%
506,789
-93,381
-16% -$7.14M
COST icon
105
Costco
COST
$431B
$41.9M 0.21%
48,636
-806
-2% -$730K
XOM icon
106
ExxonMobil
XOM
$635B
$41.6M 0.21%
345,821
+27,096
+9% +$3.14M
NBIX icon
107
Neurocrine Biosciences
NBIX
$18.1B
$41.6M 0.21%
293,096
+5,451
+2% +$790K
AEM icon
108
Agnico Eagle Mines
AEM
$71.5B
$41.5M 0.21%
244,626
+26,323
+12% +$4.42M
USB icon
109
US Bancorp
USB
$99.6B
$41.5M 0.21%
777,296
-151,592
-16% -$7.46M
ZS icon
110
Zscaler
ZS
$24.6B
$41.2M 0.21%
182,989
+12,181
+7% +$3.44M
ARGX icon
111
argenx
ARGX
$54.9B
$41M 0.2%
48,741
+541
+1% +$463K
BABA icon
112
Alibaba
BABA
$277B
$40.5M 0.2%
+276,080
New +$45M
RL icon
113
Ralph Lauren
RL
$22.7B
$40.5M 0.2%
114,408
-17,409
-13% -$5.93M
PLD icon
114
Prologis
PLD
$138B
$40.3M 0.2%
315,877
+218,104
+223% +$27.2M
LAUR icon
115
Laureate Education
LAUR
$5.22B
$40.2M 0.2%
1,194,350
-135,501
-10% -$4.18M
DDOG icon
116
Datadog
DDOG
$89.5B
$40.1M 0.2%
295,017
+22,847
+8% +$3.61M
C icon
117
Citigroup
C
$221B
$40M 0.2%
343,030
+110,932
+48% +$11.5M
BLK icon
118
Blackrock
BLK
$170B
$40M 0.2%
37,369
+6,996
+23% +$7.65M
ASND icon
119
Ascendis Pharma A/S
ASND
$16.3B
$39.9M 0.2%
186,940
+7,984
+4% +$1.65M
TGT icon
120
Target
TGT
$65.4B
$39.5M 0.2%
404,549
+146,756
+57% +$13.5M
CRNX icon
121
Crinetics Pharmaceuticals
CRNX
$8.88B
$38.7M 0.19%
830,961
+85,867
+12% +$3.82M
MTD icon
122
Mettler-Toledo International
MTD
$27.9B
$38.3M 0.19%
27,436
+429
+2% +$599K
TRV icon
123
Travelers Companies
TRV
$82.5B
$37.7M 0.19%
129,951
-41,743
-24% -$11.7M
MDGL icon
124
Madrigal Pharmaceuticals
MDGL
$12.3B
$37.2M 0.19%
63,906
+13,941
+28% +$7.12M
NUVL
125
DELISTED
Nuvalent
NUVL
$36M 0.18%
358,013
+28,292
+9% +$2.79M

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.